返回 Agenda
SESSION 9: EVALUATION OF RISK MINIMISATION EFFECTIVENESS
Session Chair(s)
Michael Forstner, PHD, MPH, MSC
Managing Director, Head of Pharmacoepidemiology Practice
Mesa Laubela-Consulting, Switzerland
- Tools and methodologies available
- Levels of metrics
- Required evaluation levels and examples of satisfactory results
Speaker(s)
EVALUATION OF RISK MINIMISATION EFFECTIVENESS
Michael Forstner, PHD, MPH, MSC
Mesa Laubela-Consulting, Switzerland
Managing Director, Head of Pharmacoepidemiology Practice